Rituximab: Current status as therapy for malignant and Benign hematologic disorders

Nihal E. Abdulla, Mary J. Ninan, Avi B. Markowitz

    Research output: Contribution to journalReview articlepeer-review

    14 Scopus citations

    Fingerprint

    Dive into the research topics of 'Rituximab: Current status as therapy for malignant and Benign hematologic disorders'. Together they form a unique fingerprint.

    Medicine & Life Sciences